1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Storm Therapeutics Limited is currently managing 1 pending office action. This case is under the review of 1 distinct examiner, HOPKINS, SAMANTHA LAKE. As the busiest examiner for the company, HOPKINS, SAMANTHA LAKE is handling 1 pending office action, representing the full extent of the company's current pending matters. The data shows 0 distinct art units associated with these filings, indicating a highly specific status for the current pending matter.
The prosecution is currently centralized under a single examiner, making the outcome of this individual case critical for the company's immediate patent objectives. With 1 distinct examiner and 0 distinct art units involved, the company's immediate patent strategy is focused on a single point of interaction within the USPTO. Practitioners should prioritize the relationship with HOPKINS, SAMANTHA LAKE to move the application forward, as there are no other active matters in the portfolio to provide alternative paths to allowance.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOPKINS, SAMANTHA LAKE | 1 | 60.7% | +61.5% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18565336 | COMBINATION THERAPIES COMPRISING A METTL3 INHIBITOR AND A FURTHER ANTICANCER AGENT | HOPKINS, SAMANTHA LAKE | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18565336 | COMBINATION THERAPIES COMPRISING A METTL3 INHIBITOR AND A FURTHER ANTICANCER AGENT | HOPKINS, SAMANTHA LAKE | — | §112Other | Non-Final OA | — | Pending | Nov 29, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialStorm Therapeutics Limited has 1 pending office actions as of October 2026, spread across 0 art units and 1 examiners.
Samantha Lake Hopkins has the most, with 1 of Storm Therapeutics Limited's pending office actions.
